Pam R. Taub, MD, FACC, FASPC
George L. Bakris, MD
Gerasimos S. Filippatos, MD, FESC, FHFA, FHFSA(h)
Reducing Morbidity and Mortality in Patients with CKD in T2D: New Late-Breaking Data
Reducing Morbidity and Mortality in Patients with CKD in T2D: New Late-Breaking…
Shelley Zieroth, MD
Worsening Heart Failure: The How, Why, and When of Novel Treatment Options
Javier Morales, MD, FACP, FACE
Angela Yee-Moon Wang, MD, FACP, FACE
A New Option for Cardiorenal Protection for Patients with CKD in T2D
Mark J. Alberts, MD
Matthew Jay Budoff, MD
Lawrence A. Leiter, MD
Omega-3 Icosapent Ethyl and Stroke Reduction in Atherosclerotic Vascular Disease
Peter Libby, MD
Prof. Kausik Ray, MBChB, MD, MPhil
Panel Discussion on AHA Symposium: Clinical Rundown—3 Hot Topic Sessions on ASCVD Risk Reduction
Panel Discussion on AHA Symposium: Clinical Rundown—3 Hot Topic Sessions on ASC…
